Abstract
Glutamate receptor subunit 4 (GluA4) is highly expressed by neural cells sensitive to excitotoxicity, and is the predominant subunit expressed by oligodendrocyte precursor cells (OPC) during a key period of vulnerability to hypoxic‐ischemic injury. Therefore, transcriptional networks downstream of excitotoxic GluA4 activation represent a promising area for therapeutic intervention. In this work, we identify the CCAAT binding transcription factor NF‐Yb as a novel transcriptional regulator of Gria4 (GluA4 gene), and a controller of excitotoxic death in the oligodendroglial lineage. We describe a novel regulatory region within Gria4 containing CCAAT sequences whose binding by NF‐Yb is regulated by excitotoxicity. Excitotoxicity‐induced alterations in NF‐Yb binding are associated with changes in Gria4 transcription, while knockdown of NF‐Yb alters the transcription of reporter constructs containing this regulatory region. Data from immortalized and primary OPC reveal that RNAi and pharmacological disruption of NF‐Yb alter Gria4 transcription, with the latter inducing apoptosis and influencing a set of apoptotic genes similarly regulated during excitotoxicity. These data provide the first definition of a trans‐acting mechanism regulating Gria4, and identify the NF‐Y network as a potential source of pharmacological targets for promoting OPC survival.
Highlights
We used excitotoxic levels of AMPAR stimulation to uncover mechanisms regulating the expression of Glutamate receptor subunit 4 (GluA4) in cells of the oligodendrocyte lineage
We identified an intronic regulatory region harboring binding sites for NF-Yb, whose binding by this transcription factor are down-regulated during excitotoxic injury
Decreased NF-Yb binding is accompanied by a reduction in the levels of GluA4 mRNA and protein, an effect mimicked at the transcriptional level by siRNA knockdown of NF-Yb
Summary
Mediated injury responses (Groom, Smith, & Turski, 2003; Kanwar, Oligodendrocyte precursor cells (OPC) express AMPA-type glutamate Kanwar, & Krissansen, 2004; Pitt, Werner, & Raine, 2000). Excitotoxic injury induces OPC and oligodendrocyte cell death through stress-induced apoptotic pathways involving the Bcl-2 family (Ness, Romanko, Rothstein, Wood, & Levison, 2001; Ness, Scaduto, & Wood, 2004; Sanchez-Gomez, Alberdi, Ibarretxe, Torre, & Matute, 2003; Sanchez-Gomez, Alberdi, Perez-Navarro, Alberch, & Matute, 2011; Simonishvili, Jain, Li, Levison, & Wood, 2013). These processes are tightly regulated by the expression of pro- and anti-apoptotic Bcl-2 genes (Kumar & Cakouros, 2004; Riley, Sontag, Chen, & Levine, 2008), the transcriptional networks stimulated by excitotoxic injury represent promising targets for therapies aiming to reduce excitotoxic injury and cell death. We provide data highlighting the therapeutic potential of the NF-Y transcriptome, with siRNA and pharmacological-mediated disruption of the NFY pathway compromising oligodendroglial viability and regulating similar apoptotic genes to those influenced by excitotoxic injury
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.